Working…
COVID-19 is an emerging, rapidly evolving situation.
Get the latest public health information from CDC: https://www.coronavirus.gov.

Get the latest research information from NIH: https://www.nih.gov/coronavirus.
ClinicalTrials.gov
ClinicalTrials.gov Menu
Trial record 4 of 63 for:    Lixisenatide

Study to Evaluate the Effect of Lixisenatide in Patient With Parkinson's Disease (LixiPark)

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details.
 
ClinicalTrials.gov Identifier: NCT03439943
Recruitment Status : Active, not recruiting
First Posted : February 20, 2018
Last Update Posted : August 25, 2020
Sponsor:
Collaborators:
Cure Parkinson
Réseau NS-Park
EUCLID
Sanofi
Information provided by (Responsible Party):
University Hospital, Toulouse

No Study Results Posted on ClinicalTrials.gov for this Study
Recruitment Status : Active, not recruiting
Estimated Primary Completion Date : September 2021
Estimated Study Completion Date : December 2021